Pascal Biosciences Confirms Specific Cannabinoids Combat Coronavirus

Author's Avatar
Sep 23, 2020
Article's Main Image

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / September 23, 2020 / Pascal Biosciences Inc. (TSXV:PAS, Financial)(OTC PINK:BIMUF) ("Pascal" or the "Company") today announced the Company has confirmed an earlier report that certain cannabinoids block replication of SARS-CoV-2, the coronavirus that causes COVID-19. Four different laboratories have now experimentally verified the antiviral activity of a cannabinoid. In addition, several cannabinoids have been tested, and the optimal compound has been chosen for further study. The best cannabinoid had potency similar to remdesivir in two different assays. Remdesivir is an approved drug from Gilead that improves recovery time for COVID-19 patients.